NCT00274417View on ClinicalTrials.gov

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)

NAUnknownINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

May 31, 2009

Conditions

Benign Prostatic HyperplasiaLower Urinary Tract Symptoms

Interventions

DRUG

dutasteride

Trial Locations (2)

23454

Urology of Virginia, Virginia Beach

23510

Urology of Virginia, Norfolk

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Urology of Virginia

OTHER

NCT00274417 - Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP) | Biotech Hunter | Biotech Hunter